Carolina Medical Lab Group INC.

Carolina Medical Lab Group INC. was paid $2.54M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 11% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in North Carolina

Rank by total paid#31 of 128

Median peer was paid$268K

This provider vs. median9.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	62,998	$593K
2019	38,885	$358K
2020	34,876	$285K
2021	59,262	$454K
2022	66,736	$400K
2023	42,529	$223K
2024incomplete	35,275	$231K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	11%	5,706	2,756	$272K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	11%	13,986	10,418	$268K
80053	Comprehensive metabolic panel	8.1%	36,204	24,551	$207K
80061	Lipid panel	7.2%	23,326	17,583	$184K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	6.9%	38,963	25,309	$177K
84443	Thyroid stimulating hormone (TSH)	6.8%	22,210	13,936	$173K
83036	Hemoglobin; glycosylated (A1C)	5.5%	21,659	15,955	$140K
36415	Collection of venous blood by venipuncture	4.2%	35,512	21,684	$106K
88312		2.7%	549	430	$68K
84481		2.4%	5,313	3,993	$62K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	2.3%	3,844	2,186	$60K
83550		2.3%	10,611	6,669	$58K

88 more codes

82607		2.3%	6,439	$58K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.0%	3,603	$50K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.8%	904	$47K
83540		1.8%	11,082	$45K
80048	Basic metabolic panel (calcium, ionized)	1.5%	6,356	$37K
80050	General health panel	1.5%	5,691	$37K
87086	Culture, bacterial; quantitative colony count, urine	1.4%	5,780	$36K
82746		1.3%	3,752	$34K
83735		1.3%	7,020	$33K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.2%	1,590	$30K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.2%	1,588	$30K
84153		<1%	1,436	$20K
84436		<1%	4,399	$19K
84479		<1%	4,252	$19K
87186		<1%	2,459	$16K
80074		<1%	363	$15K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	660	$14K
87077		<1%	2,098	$14K
84439		<1%	3,070	$14K
88365		<1%	161	$13K
82728		<1%	1,680	$13K
87081		<1%	2,142	$12K
83880		<1%	432	$11K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	708	$10K
88141		<1%	658	$10K
86803		<1%	891	$10K
85027		<1%	2,305	$10K
86376		<1%	776	$8K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	406	$7K
86701		<1%	922	$7K
86696		<1%	665	$7K
81003		<1%	3,148	$6K
80164		<1%	506	$5K
85610		<1%	1,342	$5K
82140		<1%	328	$5K
87340		<1%	655	$4K
86695		<1%	625	$4K
80076		<1%	689	$4K
87536		<1%	212	$4K
86140		<1%	1,004	$4K
88311		<1%	392	$4K
83970		<1%	197	$3K
82043		<1%	1,187	$3K
82570		<1%	1,414	$3K
85651		<1%	1,073	$3K
86593		<1%	772	$3K
81007		<1%	916	$3K
87070		<1%	310	$2K
86038		<1%	252	$2K
86592		<1%	790	$2K
84703		<1%	453	$2K
81001		<1%	769	$2K
83655		<1%	276	$2K
84403		<1%	69	$2K
80069		<1%	571	$1K
82248		<1%	646	$1K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	15,648	$1K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	271	$1K
80055		<1%	36	$1K
88104		<1%	39	$968.20
87220		<1%	136	$724.96
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	118	$652.58
87101		<1%	107	$623.77
84100		<1%	184	$584.50
87088		<1%	116	$565.39
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	18	$560.18
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	2,060	$545.40
83002		<1%	35	$457.01
87522	Neg quan hep c or qual rna	<1%	14	$446.04
83001		<1%	38	$443.11
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	13	$328.24
82247		<1%	72	$296.00
83690		<1%	44	$290.50
82652		<1%	19	$274.48
84146		<1%	21	$251.94
84702		<1%	54	$250.68
84550		<1%	94	$247.98
84134		<1%	16	$218.16
82565		<1%	47	$173.16
84478		<1%	43	$164.15
84450		<1%	46	$155.93
82150		<1%	14	$103.89
82310		<1%	18	$94.83
82947		<1%	20	$49.65
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	389	$38.99
85018		<1%	29	$16.95
83021		0%	15	$0.00
S3600	Stat laboratory request (situations other than s3601)	0%	20	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialIDLIBI, OSAMA (VICE PRESIDENT)